On August 1, 2024, BNP Paribas and AXA announced that they entered into exclusive negotiations for the acquisition of AXA Investment Management and a long-term partnership in asset management. AXA and ...

The formation of this new platform marks a major milestone in the development and growth journey of the IPS division. It will fully benefit from BNP Paribas' integrated model, in close collaboration ...

Size matters ever more in asset management, where the commonly stated rule is that any asset manager with under $1 trillion under management is sub-scale. The asset management units of BNP Paribas and ...

AXA IM Alts has acquired capital and private debt financing firm Capza, according to a news release. AXA IM Alts is now the majority shareholder of Capza and will increase its position to full ...

AXA IM Alts, a global alternative investment firm, has continued its U.S. expansion with the acquisition of Vida at Health Village, a 285-unit multifamily community in the Uptown area of Orlando, Fla.

Alongside the acquisition, AXA has committed $200 million to WCP’s secondaries investment strategy The deal is expected to close in the second quarter of this year Founded in 2001, WCP managed $1.9 ...

AXA Investment Managers has cut its exposure to French banking stocks and sees no quick reversal in the recent rise in sovereign yields, according to portfolio manager Gilles Guibout. The stock-market ...

AXA IM Alts said it’s starting a new fund to focus on high-rated broadly traded asset-backed securities. The AXA IM Investment Grade ABS Fund plans to invest in a spectrum of consumer-linked assets ...

Axa IM Alts bought Data4 in 2018 Axa IM Alts is a global firm in alternative investments with over €186bn of assets under management This transaction will be Brookfield’s first major entry into the ...

Defined contribution master trust Smart Pension, London, is partnering with AXA Investment Managers on a biodiversity fund, the organizations said in a joint news release Tuesday. The strategy for the ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. For the transaction, AXA IM first purchsed €5 million of ...

SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced it has raised a $32 million Series A ...